Cardio Diagnostics Holdings CDIO
NASDAQ CDIO
$1.89 +0.02 (+1.34%)
As of: Sep 30, 2026 · 3:21 PM EDT

Cardio Diagnostics Holdings (CDIO) EBIT Margin (2022 - 2026)

Updated

Cardio Diagnostics Holdings (CDIO) posted EBIT Margin of -27950.50% for Q2 2026, down 5492.99 percentage points from -22457.51% a year earlier but up 38647.89 percentage points from the prior quarter.

Analysis

Cardio Diagnostics Holdings (CDIO) EBIT Margin (2022 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBIT Margin at Cardio Diagnostics Holdings was -44690.68%, down 12729.70 percentage points year-over-year; for FY2025, it came in at -43737.46%, down 19759.59 percentage points from FY2024.

  • Annual EBIT Margin shows a four-year change of +25124.70 percentage points (FY2021 to FY2025).
  • In prior years, Cardio Diagnostics Holdings' EBIT Margin was -23977.86% in FY2024 (+18462.56 pp), -42440.43% in FY2023 (+436343.89 pp), -478784.32% in FY2022 (-409922.16 pp) and -68862.15% in FY2021.
  • Quarterly EBIT Margin has run from a low of -250321.79% in Q4 2022 to a high of -14398.71% in Q3 2023 over five years.
  • On a year-over-year basis, EBIT Margin increased in 1 of the last eight quarters, with an average year-over-year change of -13727.53 percentage points.
  • The strongest year-over-year quarter for EBIT Margin in the past five years was Q4 2023, with a gain of 221282.28 percentage points; the weakest was Q1 2025, with a drop of 147358.56 percentage points.
  • According to Business Quant data, EBIT Margin for the three prior quarters was -66598.40% (Q1 2026), -41159.55% (Q4 2025) and -59950.86% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 13.44%
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 33.60%
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 18.08%
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 25.18%
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 21.65%
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 29.48%
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 13.31%
10 Cardio Diagnostics Holdings 5.53 Mn -18.60 Mn - -27,950.50%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -27,950.50%
Mar 31, 2026 -66,598.40%
Dec 31, 2025 -41,159.55%
Sep 30, 2025 -59,950.86%
Jun 30, 2025 -22,457.51%
Mar 31, 2025 -173,463.83%
Dec 31, 2024 -33,608.20%
Sep 30, 2024 -21,412.87%
Jun 30, 2024 -16,295.55%
Mar 31, 2024 -26,105.27%
Dec 31, 2023 -29,039.51%
Sep 30, 2023 -14,398.71%
Jun 30, 2023 -148,008.17%
Dec 31, 2022 -250,321.79%
API Access

Cardio Diagnostics Holdings EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=CDIO&period=max&api_key=YOUR_API_KEY